Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Human Vaccines & Immunotherapeutics|June 18, 2015
Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trialYujia Kong, Wei Zhang, Zhiwei Jiang, et al.Cancer Medicine|December 4, 2021
Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non-small cell lung cancerWenjing Zhang, Fuyan Shi, Yujia Kong, et al.Medicine|April 26, 2020
A preliminary study on submariners with xerostomia after a 3-month deploymentGuowei Wang, Baodong Zhao, Yujia Kong, et al.Heliyon|March 27, 2024
Metal ion stimulation-related gene signatures correlate with clinical and immunologic characteristics of gliomaChengzhi Jiang, Binbin Zhang, Wenjuan Jiang, et al.Frontiers in Oncology|December 6, 2019
Diagnosis and Management of Mixed Gestational Trophoblastic Neoplasia: A Study of 16 Cases and a Review of the LiteratureYujia Kong, Guangshi Tao, Liju Zong, et al.Journal of Immunology Research|April 24, 2020
Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine CervixLiju Zong, Qianqian Zhang, Yuncan Zhou, et al.NPJ Precision Oncology|June 23, 2022
Favorable immune checkpoint inhibitor outcome of patients with melanoma and NSCLC harboring FAT1 mutationsWenjing Zhang, Yunfeng Tang, Yuxian Guo, et al.Cancer Science|December 30, 2021
An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinomaWenjing Zhang, Yuting Li, Juncheng Lyu, et al.Frontiers in Immunology|January 28, 2022
Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in MelanomaWenjing Zhang, Yujia Kong, Yuting Li, et al.Aging|August 3, 2023
SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLCFengxiao An, Wenjing Zhang, Yuxian Guo, et al.Pageof 6